comparemela.com

Latest Breaking News On - Director lori jean robinson - Page 4 : comparemela.com

Barclays Increases Centene (NYSE:CNC) Price Target to $104 00

Centene (NYSE:CNC – Get Free Report) had its price objective lifted by investment analysts at Barclays from $101.00 to $104.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target indicates a potential upside of 39.02% from the stock’s previous close. […]

Centene (NYSE:CNC) Given New $104 00 Price Target at Barclays

Centene (NYSE:CNC – Free Report) had its target price increased by Barclays from $101.00 to $104.00 in a research note published on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other research firms have also issued reports on CNC. Deutsche Bank Aktiengesellschaft upped their target price on […]

Centene (NYSE:CNC) Rating Increased to Strong-Buy at StockNews com

Centene (NYSE:CNC) Rating Increased to Strong-Buy at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Centene (NYSE:CNC) Stock Rating Reaffirmed by Oppenheimer

Centene (NYSE:CNC) Stock Rating Reaffirmed by Oppenheimer
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Centene s (CNC) Outperform Rating Reiterated at Oppenheimer

Oppenheimer reaffirmed their outperform rating on shares of Centene (NYSE:CNC – Free Report) in a research note published on Monday morning, Benzinga reports. Oppenheimer currently has a $110.00 price target on the stock. Other analysts have also issued reports about the company. Barclays began coverage on Centene in a report on Wednesday, March 6th. They […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.